[Legal requirements for the coating of coronary stents with medications by cardiologists outside clinical investigations. Information of the Federal Institute for Medications and Medical Products and the central position of the various regions for health preservation in using medications and medical products (ZLG)].
von Mallek
Dirk
D
Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Abteilung Medizinprodukte, Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany. mallek@bfarm.de
Tolle
I
I
Stephan
K
K
Edelhäuser
R
R
Heinz
B
B
D000047:Academies and Institutes; D002309:Cardiology / Q000331:legislation & jurisprudence*; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000592:standards* / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy / Q000628:therapy*; D005858:Germany; D006801:Humans; D007883:Legislation, Medical; D015607:Stents
D002317:Cardiovascular Agents